Where does the trial-to-paid sequence pick up?
Onboarding and trial-to-paid emails do two different jobs. The onboarding sequence has one goal: get the user to their aha moment — the point where the product's value is obvious. That is activation. It is not a purchase.
The trial-to-paid sequence picks up from there. It assumes the value is already delivered and does the one thing onboarding does not: ask for the card. Where onboarding maps to the activation lifecycle stage, this sequence maps to the trial-to-paid decision — a short, well-timed push that ends before the trial does.
What does the sequence look like, and when does each email go out?
Six emails, sequenced across the trial. Some fire on behavior, some on the calendar. The first two react to what the user does; the last four count down to expiry. A journey engine handles the mix — a wait_for_event node holds the activation email until the user actually activates, and a branch node routes activated and passive trialists down different paths.
| 14-day trial | 30-day trial | |
|---|---|---|
| Activation check | Day 2 | Day 3 |
| Mid-trial value recap | Day 7 | Day 15 |
| Objection handler (T-3) | Day 11 | Day 27 |
| Urgency (T-1) | Day 13 | Day 29 |
| Expiry / grace day | Day 14–15 | Day 30–31 |
| Post-expiry win-back | Day 18–21 | Day 34–37 |
What should each email actually say?
The recap emails should tie value to what the user actually did in the product, not to your feature list. 'You built 5 segments and shipped 2 journeys — here is what that turns into on a paid plan' beats 'our platform is powerful.' Specifics that mirror their own activity are the strongest argument you have.
- A value recap tied to a real in-product action, with a number where you have one
- Exactly one objection, named and answered — price, migration effort, or a missing integration
- Optional social proof: one line, one number, from a comparable team
- One clear CTA — upgrade — and nothing competing with it
- Plain language on what happens at expiry: what they keep, what they lose
Pick the single objection most likely to stall the purchase and answer it directly — do not list five. This is the judgment a lifecycle marketer brings: knowing which objection is real for this segment. If you are building the wider system these emails live in, see lifecycle marketing for startups.
The expiry day and the grace period
The expiry-day email is not a footnote. Send it the moment the trial ends: state that access has changed, and give one path back. Then add a short grace window — a day or two where the account still works — and say so. If you collect a card upfront, note the timing rules: Userlist points out that card networks such as Visa require at least seven days' notice before a trial converts to a paid charge, so your reminders have to run early enough to comply.
Do not treat expiry as the end. Encharge, citing a MadKudu analysis, reports that roughly half of SaaS conversions can happen after the trial ends — which is why a post-expiry win-back earns its place. Send a lighter re-engagement a few days later. And once a user does convert, the next leak is billing: a failed charge quietly churns a paying customer, so pair this sequence with dunning and failed-payment recovery.
Should you offer a discount?
Sparingly. A standing 20% off in every trial-end email trains people to let the trial lapse and wait for the coupon — you teach your best-intent users to stall. Prefer honest urgency and a value recap during the live trial. Reserve a discount for a targeted win-back to users who lapsed without converting, where it is a genuine second offer, not a reflex. Tools like Customer.io, Encharge, and Loops can gate that offer to a specific lapsed segment.
How do you measure trial-to-paid conversion?
Trial-to-paid conversion rate is paying customers divided by trials started in the same cohort — cohort by signup week, not by calendar month, or late signups distort the rate. Segment it by activated versus not; the activated cohort is the one your emails can move. Benchmarks vary widely with trial design: Baremetrics reports opt-in trials (no card required) often convert around 15–25%, while card-upfront trials often run higher, roughly 40–60%. Treat those as reference points, not targets — your product and audience set the real number.